Related Experiment Video
Updated: Mar 20, 2026

Identification of Cyclin-dependent Kinase 1 Specific Phosphorylation Sites by an In Vitro Kinase Assay
Published on: May 3, 2018
Mechanism of p27 Unfolding for CDK2 Reactivation
Soumya Lipsa Rath1, Sanjib Senapati1
1Computational Biophysics Group, Bhupat and Jyoti Mehta School of Biosciences and Department of Biotechnology, Indian Institute of Technology Madras, Chennai, Tamil Nadu, India.
Abstract:
Cell-cycle regulatory protein, CDK2 is active when bound to its complementary partner protein, CyclinA or E. Recent discovery of the Kip/Cip family of proteins has indicated that the activity of CDK2 is also regulated by a member protein, p27. Although, the mechanism of CDK2 inhibition by p27 binding is known from crystal structure, little is known about the mechanism of CDK2 reactivation. Here, we execute classical and accelerated molecular dynamics simulations of unphosphorylated- and phosphorylated-p27 bound CDK2/CyclinA to unravel the CDK2 reactivation mechanism at molecular-to-atomic detail. Results suggest that the phosphorylation of p27 Y88 residue (pY88-p27) first disrupts the p27/CDK2 hybrid β-sheet and subsequently ejects the p27 310 helix from CDK2 catalytic cleft. The unbinding of p27 from CDK2/CyclinA complex, thus, follows a two-step unfolding mechanism, where the 310 helix ejection constitutes the rate-limiting step. Interestingly, the unfolding of p27 leaves CDK2/CyclinA in an active state, where the prerequisite CDK2-CyclinA interfacial contacts were regained and ATP achieved its native position for smooth transfer of phosphate. Our findings match very well with NMR chemical shift data that indicated the flip-out of p27 310 helix from CDK2 pocket and kinetic experiments that exhibited significant kinase activity of CDK2 when saturated with pY88-p27.
Insights
Phosphorylation of p27 protein triggers CDK2 reactivation by disrupting its binding and ejecting a key helix. This two-step process restores CDK2/CyclinA activity, crucial for cell-cycle regulation.
Area of Science:
- Biochemistry
- Molecular Biology
- Structural Biology
Background:
- Cyclin-dependent kinase 2 (CDK2) activity is regulated by cyclins and inhibitors like p27.
- While CDK2 inhibition by p27 is understood, the reactivation mechanism remains unclear.
Purpose of the Study:
- To elucidate the molecular mechanism of CDK2 reactivation from p27 inhibition.
- To investigate the role of p27 phosphorylation in CDK2/CyclinA complex dynamics.
Main Methods:
- Classical and accelerated molecular dynamics simulations.
- Analysis of unphosphorylated- and phosphorylated-p27 bound CDK2/CyclinA complexes.
- Comparison with NMR chemical shift data and kinetic experiments.
Main Results:
- Phosphorylation of p27 at Y88 disrupts the p27/CDK2 interaction and ejects the p27 310 helix.
- CDK2 reactivation follows a two-step unfolding mechanism, with helix ejection as the rate-limiting step.
- Reactivated CDK2/CyclinA regains essential contacts and ATP binding for kinase activity.
Conclusions:
- The study reveals a detailed molecular mechanism for CDK2 reactivation.
- Phosphorylated p27 acts as a trigger for releasing CDK2 inhibition.
- Findings provide insights into cell-cycle control and potential therapeutic targets.
More Related Videos
10:33Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors
Published on: October 26, 2015
12:02Studying Cell Cycle-regulated Gene Expression by Two Complementary Cell Synchronization Protocols
Published on: June 6, 2017
Related Concept Videos
Inhibition of Cdk Activity
Inhibition of CDK Activity
Positive Regulator Molecules
Positive Regulator Molecules
M-Cdk Drives Transition Into Mitosis
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
M-Cdk Drives Transition Into Mitosis